Tamoxifen is a selective estrogen receptor modulator (SERM), and it is commonly used to treat all stages of hormone-dependent or ER+ breast cancers, however, the efficacy of tamoxifen as a breast cancer therapy is not satisfactory because of the development of resistance to tamoxifen [53]. This evidence concerns the gene ESR1 and breast carcinoma.